Cleara Biotech B.V.
Peptide-based clearance of cancer driven by impaired p53
10 employees · est. 2018 · Utrecht, The Netherlands
Mediar Therapeutics
Mediar Therapeutics is a clinical stage company advancing first-in-class therapies to halt fibrosis progression.
55 employees · est. 2019 · Boston, United States
Cleara Biotech B.V. is the older company (2018 vs 2019); Mediar Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Cleara Biotech B.V. | Mediar Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2019 |
| Headquarters | ||
| Headquarters | Utrecht, The Netherlands | Boston, United States |
| Employees | ||
| Employees | 10 | 55 larger |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Convertible Note | Series A |
| Total Funding | ||
| Total Funding | $2.50M | $85.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical R&D, Therapeutic Development, Cancer Treatment, Senescent Cells, Precision Medicine, Biomarker Development, FOXO4 Program, Cellular Senescence, Chronic Disease Research, Metastatic Cancer Therapy, Molecular Pathways, Innovative Therapeutics, Proprietary Technology, Clinical Development, D-amino Acid Pipeline | Biotech Company, Fibrosis Treatment, Preclinical Stage, Novel Targets, Blood Biomarkers, Disease Progression, Clinical Development |
| Website | ||
| Website | clearabiotech.com | mediartx.com |
About Cleara Biotech B.V.
Cleara Biotech B.V., founded in 2018 and headquartered in The Netherlands, operates within the Biotechnology sector, focusing on targeting cellular senescence to extend human healthspan and counteract late-stage cancer. This biopharmaceutical R&D firm specializes in developing therapies for cancer...
About Mediar Therapeutics
Mediar Therapeutics is a preclinical stage biotech company with a mission to develop innovative treatments to halt or even reverse fibrosis. The company takes a pioneering approach by targeting the fibrotic mediators driving disease progression. Founded in 2019, Mediar is deeply rooted in its unders...
We will tell you when either one moves
BounceWatch watches Cleara Biotech B.V. and Mediar Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cleara Biotech B.V. and Mediar Therapeutics — by email.
Frequently Asked Questions
Compare Cleara Biotech B.V. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cleara Biotech B.V. on 12 Sep 2024, and Mediar Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
